Legal & General Group Plc

Position in CTMX — CytomX Therapeutics, Inc.

CIK 764068 London, X0

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$462,423

-$204,473 QoQ

Shares Held

123,313

-13.1% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 178 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. CTMX ranks #139 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$462,423	123,313	-13.1%	Shares	Defined	2026-08-14
2026-03-31	$666,896	141,893	+1594.9%	Shares	Defined	2026-05-08
2022-03-31	$22,352	8,372	+3.9%	Shares	Defined	2022-05-16
2021-12-31	$34,881	8,056	-58.7%	Shares	Defined	2022-02-14
2021-09-30	$99,395	19,528	+103.7%	Shares	Defined	2021-11-15
2021-06-30	$60,678	9,586	+10.0%	Shares	Defined	2021-08-12
2021-03-31	$67,373	8,716	+29.8%	Shares	Defined	2021-05-17
2020-12-31	$43,982	6,715	0.0%	Shares	Defined	2021-02-12
2020-09-30	$44,653	6,715	-22.5%	Shares	Defined	2020-11-13
2020-06-30	$72,153	8,662	+4.7%	Shares	Defined	2020-08-14
2020-03-31	$63,453	8,273	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.